Clinical Trial Update: Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating paliperidone ER (Invega) for depressive symptoms in schizophrenia patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED